[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Rheumatology Therapeutics Market Report 2018

March 2018 | 98 pages | ID: U182F36734FQEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Rheumatology Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Rheumatology Therapeutics in these regions, from 2013 to 2025 (forecast).
United States Rheumatology Therapeutics market competition by top manufacturers/players, with Rheumatology Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AbbVie
  • Pfizer
  • Bristol-Myers Squibb Company
  • Merck & Co
  • Amgen
  • Janssen Biotech
  • Novartis AG
  • Genentech
  • Takeda Pharmaceutical
  • Sanofi
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Lupus
  • Gout
  • Ankylosing Spondylitis
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Retail Pharmacy
  • Online Pharmacy
  • Hospitals
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Rheumatology Therapeutics Market Report 2018

1 RHEUMATOLOGY THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Rheumatology Therapeutics
1.2 Classification of Rheumatology Therapeutics by Product Category
  1.2.1 United States Rheumatology Therapeutics Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Rheumatology Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Rheumatoid Arthritis
  1.2.4 Osteoarthritis
  1.2.5 Lupus
  1.2.6 Gout
  1.2.7 Ankylosing Spondylitis
  1.2.8 Other
1.3 United States Rheumatology Therapeutics Market by Application/End Users
  1.3.1 United States Rheumatology Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Retail Pharmacy
  1.3.3 Online Pharmacy
  1.3.4 Hospitals
1.4 United States Rheumatology Therapeutics Market by Region
  1.4.1 United States Rheumatology Therapeutics Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Rheumatology Therapeutics Status and Prospect (2013-2025)
  1.4.3 Southwest Rheumatology Therapeutics Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Rheumatology Therapeutics Status and Prospect (2013-2025)
  1.4.5 New England Rheumatology Therapeutics Status and Prospect (2013-2025)
  1.4.6 The South Rheumatology Therapeutics Status and Prospect (2013-2025)
  1.4.7 The Midwest Rheumatology Therapeutics Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Rheumatology Therapeutics (2013-2025)
  1.5.1 United States Rheumatology Therapeutics Sales and Growth Rate (2013-2025)
  1.5.2 United States Rheumatology Therapeutics Revenue and Growth Rate (2013-2025)

2 UNITED STATES RHEUMATOLOGY THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Rheumatology Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Rheumatology Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Rheumatology Therapeutics Average Price by Players/Suppliers (2013-2018)
2.4 United States Rheumatology Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Rheumatology Therapeutics Market Concentration Rate
  2.4.2 United States Rheumatology Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Rheumatology Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RHEUMATOLOGY THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Rheumatology Therapeutics Sales and Market Share by Region (2013-2018)
3.2 United States Rheumatology Therapeutics Revenue and Market Share by Region (2013-2018)
3.3 United States Rheumatology Therapeutics Price by Region (2013-2018)

4 UNITED STATES RHEUMATOLOGY THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Rheumatology Therapeutics Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Rheumatology Therapeutics Revenue and Market Share by Type (2013-2018)
4.3 United States Rheumatology Therapeutics Price by Type (2013-2018)
4.4 United States Rheumatology Therapeutics Sales Growth Rate by Type (2013-2018)

5 UNITED STATES RHEUMATOLOGY THERAPEUTICS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Rheumatology Therapeutics Sales and Market Share by Application (2013-2018)
5.2 United States Rheumatology Therapeutics Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES RHEUMATOLOGY THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb Company
  6.3.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co
  6.4.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Amgen
  6.5.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Janssen Biotech
  6.6.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Janssen Biotech Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Novartis AG
  6.7.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis AG Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Genentech
  6.8.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Genentech Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Takeda Pharmaceutical
  6.9.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Pharmaceutical Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Sanofi
  6.10.2 Rheumatology Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sanofi Rheumatology Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 RHEUMATOLOGY THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Rheumatology Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rheumatology Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rheumatology Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rheumatology Therapeutics Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RHEUMATOLOGY THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Rheumatology Therapeutics Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Rheumatology Therapeutics Sales Volume Forecast by Type (2018-2025)
11.3 United States Rheumatology Therapeutics Sales Volume Forecast by Application (2018-2025)
11.4 United States Rheumatology Therapeutics Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Rheumatology Therapeutics
Figure United States Rheumatology Therapeutics Market Size (K Units) by Type (2013-2025)
Figure United States Rheumatology Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure Rheumatoid Arthritis Product Picture
Figure Osteoarthritis Product Picture
Figure Lupus Product Picture
Figure Gout Product Picture
Figure Ankylosing Spondylitis Product Picture
Figure Other Product Picture
Figure United States Rheumatology Therapeutics Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Rheumatology Therapeutics by Application in 2017
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure United States Rheumatology Therapeutics Market Size (Million USD) by Region (2013-2025)
Figure The West Rheumatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Rheumatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Rheumatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Rheumatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Rheumatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Rheumatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Rheumatology Therapeutics Sales (K Units) and Growth Rate (2013-2025)
Figure United States Rheumatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Rheumatology Therapeutics Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Rheumatology Therapeutics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Rheumatology Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Rheumatology Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Rheumatology Therapeutics Sales Share by Players/Suppliers
Figure United States Rheumatology Therapeutics Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Rheumatology Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Rheumatology Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Rheumatology Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Rheumatology Therapeutics Revenue Share by Players/Suppliers
Table United States Market Rheumatology Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Rheumatology Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Rheumatology Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Rheumatology Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Rheumatology Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Rheumatology Therapeutics Product Category
Table United States Rheumatology Therapeutics Sales (K Units) by Region (2013-2018)
Table United States Rheumatology Therapeutics Sales Share by Region (2013-2018)
Figure United States Rheumatology Therapeutics Sales Share by Region (2013-2018)
Figure United States Rheumatology Therapeutics Sales Market Share by Region in 2017
Table United States Rheumatology Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Rheumatology Therapeutics Revenue Share by Region (2013-2018)
Figure United States Rheumatology Therapeutics Revenue Market Share by Region (2013-2018)
Figure United States Rheumatology Therapeutics Revenue Market Share by Region in 2017
Table United States Rheumatology Therapeutics Price (USD/Unit) by Region (2013-2018)
Table United States Rheumatology Therapeutics Sales (K Units) by Type (2013-2018)
Table United States Rheumatology Therapeutics Sales Share by Type (2013-2018)
Figure United States Rheumatology Therapeutics Sales Share by Type (2013-2018)
Figure United States Rheumatology Therapeutics Sales Market Share by Type in 2017
Table United States Rheumatology Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Rheumatology Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Rheumatology Therapeutics by Type (2013-2018)
Figure Revenue Market Share of Rheumatology Therapeutics by Type in 2017
Table United States Rheumatology Therapeutics Price (USD/Unit) by Types (2013-2018)
Figure United States Rheumatology Therapeutics Sales Growth Rate by Type (2013-2018)
Table United States Rheumatology Therapeutics Sales (K Units) by Application (2013-2018)
Table United States Rheumatology Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Rheumatology Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Rheumatology Therapeutics Sales Market Share by Application in 2017
Table United States Rheumatology Therapeutics Sales Growth Rate by Application (2013-2018)
Figure United States Rheumatology Therapeutics Sales Growth Rate by Application (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure AbbVie Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure AbbVie Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Pfizer Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Pfizer Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Merck & Co Basic Information List
Table Merck & Co Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Merck & Co Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Merck & Co Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Amgen Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Amgen Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Biotech Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Janssen Biotech Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Janssen Biotech Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Novartis AG Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Novartis AG Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Genentech Basic Information List
Table Genentech Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genentech Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Genentech Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Genentech Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceutical Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Rheumatology Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Rheumatology Therapeutics Sales Growth Rate (2013-2018)
Figure Sanofi Rheumatology Therapeutics Sales Market Share in United States (2013-2018)
Figure Sanofi Rheumatology Therapeutics Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rheumatology Therapeutics
Figure Manufacturing Process Analysis of Rheumatology Therapeutics
Figure Rheumatology Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Rheumatology Therapeutics Major Players/Suppliers in 2017
Table Major Buyers of Rheumatology Therapeutics
Table Distributors/Traders List
Figure United States Rheumatology Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Rheumatology Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Rheumatology Therapeutics Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Rheumatology Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Rheumatology Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Rheumatology Therapeutics Sales Volume (K Units) Forecast by Type in 2025
Table United States Rheumatology Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Rheumatology Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Rheumatology Therapeutics Sales Volume (K Units) Forecast by Application in 2025
Table United States Rheumatology Therapeutics Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Rheumatology Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Rheumatology Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Rheumatology Therapeutics Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories